Coherus Oncology, Inc.
$1.41
-0.05 (-3.42%)
Price as of Aug 28, 2026 market close
Performance
- 1 Month
- -4.1%
- 3 Months
- -11.3%
- YTD
- -0.7%
- 1 Year
- +23.7%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Volatility 1-year annualized
- 81.0%
- Largest decline max drawdown, since Aug 2025
- -54.6%
- Risk-adjusted return Sharpe ratio, 1-year
- 0.66
Own CHRS?
See how CHRS contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.